Asset Publisher

JCTLM Members' and Stakeholders' meeting - Session 1 and 2

04 December 2013

Contact person

Publications

Working documents

JCTLM/2013-Session1-EVIDENCE-01

Agenda of the workshop on the impact of reference measurement systems on clinical evidence on 04 December 2013

JCTLM/2013-Session1-EVIDENCE-02

Welcome and introduction to JCTLM Stakeholders meetings

M. Muller

JCTLM/2013-Session1-EVIDENCE-03

Introduction to Clinical Evidence and measurements

P. Bossuyt

JCTLM/2013-Session1-EVIDENCE-04

Case study 1: Creatinine and Chronic Kidney Disease

G. Jones

JCTLM/2013-Session1-EVIDENCE-05

Case study 2: HbA1c and Diabetes

P. Gillery

JCTLM/2013-Session1-EVIDENCE-06

Case study 3: PSA ; Standardization and variability comparative study in hospitals

O. Blake

JCTLM/2013-Session1-EVIDENCE-07

Case study 4: Free Thyroxine ; Reference Measurement Systems for FT4

L. Thienpont

JCTLM/2013-Session2-COMMUTABILITY-01

Agenda of the Workshop on Commutability on 04 December 2013

JCTLM/2013-Session2-COMMUTABILITY-02

An introduction and challenges related to Commutability

G. Miller

JCTLM/2013-Session2-COMMUTABILITY-03

Commutability and traceability: an IVD Industry View1

D. Armbruster

JCTLM/2013-Session2-COMMUTABILITY-04

Comutability issues for EQA Scheme Organizer

L. Siekmann

JCTLM/2013-Session2-COMMUTABILITY-05

Improving definitions and dealing with commutability

D. Stockl

JCTLM/2013-Session2-COMMUTABILITY-06

Assessing the commutability of WHO International Standards

C. Burns

JCTLM/2013-Session2-COMMUTABILITY-07

Outcomes of WHO consultation on commutability

D. Wood

JCTLM/2013-Session2-COMMUTABILITY-08

Commutability Studies undertaken by the IRMM

I. Zegers

JCTLM/2013-Session2-COMMUTABILITY-09

Commutability studies undertaken by the NIST

K. Phinney

JCTLM/2013-Session2-COMMUTABILITY-10

Commutability studies undertaken by the LNE

V. Delatour

jctlm - simple LOGO

Asset Publisher

JCTLM